Emotional support animals can offer comfort that helps ease mental health symptoms like anxiety. Here's who might qualify and ...
Researchers have found evidence that could help explain why some anemic CKD patients are resistant to treatment with erythropoiesis stimulating agents. Patients on high-dose ESA had significantly ...
A decade of globalization: Trends in participation of investigators from lower-resource economies in phase III lung cancer trials. Background: Two ESAs (darbepoetin alfa, epoetin alfa) are ...
Once-monthly dosing of Hematide safely boosted hemoglobin in non-dialysis anemic CKD patients. BARCELONA—A novel peptide-based erythropoiesis-stimulating agent (ESA) called Hematide safely raises ...
Real-world erythropoiesis-stimulating agent (ESA) treatment patterns and outcomes among U.S. patients with lower-risk myelodysplastic syndromes (LR-MDS). This is an ASCO Meeting Abstract from the 2022 ...
Only about a quarter of patients who have myelodysplastic syndrome (MDS) experienced hematologic improvement with erythropoiesis-stimulating agents (ESAs). Patients with lower-risk myelodysplastic ...
Please provide your email address to receive an email when new articles are posted on . Patients switched to oral vadadustat had hemoglobin levels similar to those on a long-acting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback